109 related articles for article (PubMed ID: 15964360)
1. Increased expression of renin in chronic allograft nephropathy.
Oka K; Moriyama T; Takahara S; Naruse M; Namba Y; Ichimaru N; Kyo M; Kokado Y; Okuyama A; Ito T; Imai E; Aozasa K
Transplant Proc; 2005 Jun; 37(5):2131-4. PubMed ID: 15964360
[TBL] [Abstract][Full Text] [Related]
2. Prediction of chronic renal allograft dysfunction from evaluations of TGFBeta1 and the renin-angiotensin system.
Yamada K; Hatakeyama E; Arita S; Sakamoto K; Kashiwabara H; Hamaguchi K
Clin Exp Nephrol; 2003 Sep; 7(3):238-42. PubMed ID: 14586721
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and prognosis for proteinuria in renal transplant recipients.
Sancho A; Gavela E; Avila A; Morales A; Fernández-Nájera JE; Crespo JF; Pallardo LM
Transplant Proc; 2007 Sep; 39(7):2145-7. PubMed ID: 17889119
[TBL] [Abstract][Full Text] [Related]
4. A clinicopathologic study of p27(kip1) expression in renal allograft biopsy.
Oka K; Namba Y; Moriyama T; Kyo M; Tsukiyama A; Tsujimoto M; Kokado Y; Imai E; Takahara S
Transplant Proc; 2007 Dec; 39(10):3068-71. PubMed ID: 18089324
[TBL] [Abstract][Full Text] [Related]
5. Intrarenal activation of renin angiotensin system in the development of cyclosporine A induced chronic nephrotoxicity.
Shang MH; Yuan WJ; Zhang SJ; Fan Y; Zhang Z
Chin Med J (Engl); 2008 Jun; 121(11):983-8. PubMed ID: 18706245
[TBL] [Abstract][Full Text] [Related]
6. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
7. The benefits of renin-angiotensin blockade in renal transplant recipients with biopsy-proven allograft nephropathy.
Zaltzman JS; Nash M; Chiu R; Prasad R
Nephrol Dial Transplant; 2004 Apr; 19(4):940-4. PubMed ID: 15031353
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
[TBL] [Abstract][Full Text] [Related]
9. Predictors of chronic allograft nephropathy from protocol biopsies using histological and immunohistochemical techniques.
Yehia M; Matheson PJ; Merrilees MJ; Beaumont BW; Pilmore HL
Nephrology (Carlton); 2006 Jun; 11(3):261-6. PubMed ID: 16756643
[TBL] [Abstract][Full Text] [Related]
10. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme gene polymorphism in chronic allograft nephropathy.
Biselli PM; Abbud-Filho M; Ferreira-Baptista MA; de Alvarenga MP; Goloni-Bertollo EM; Pavarino-Bertelli EC
Transplant Proc; 2006 Jun; 38(5):1327-8. PubMed ID: 16797293
[TBL] [Abstract][Full Text] [Related]
12. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
Revelo MP; Federspiel C; Helderman H; Fogo AB
Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients.
Stallone G; Infante B; Schena A; Battaglia M; Ditonno P; Loverre A; Gesualdo L; Schena FP; Grandaliano G
J Am Soc Nephrol; 2005 Dec; 16(12):3755-62. PubMed ID: 16236802
[TBL] [Abstract][Full Text] [Related]
14. C4d complement split product in diagnosis of immunological activity of chronic allograft nephropathy.
Mroz A; Lewandowski Z; Cieciura T; Matłosz B; Pazik J; Kwiatkowski A; Szmidt J; Durlik M
Transplant Proc; 2006; 38(1):97-100. PubMed ID: 16504674
[TBL] [Abstract][Full Text] [Related]
15. Lipid profile in chronic allograft nephropathy.
Sahin S; Manga Sahin G; Kantarci G; Ergin H; Sezgin O
Transplant Proc; 2006 Mar; 38(2):477-9. PubMed ID: 16549152
[TBL] [Abstract][Full Text] [Related]
16. Analysis of allograft biopsy specimens in renal transplants with proteinuria: is proteinuria a culprit of graft loss?
Kang CM; Kim GH; Lee CH; Kwak JY; Kwon OJ
Transplant Proc; 2005 Mar; 37(2):984-6. PubMed ID: 15848598
[TBL] [Abstract][Full Text] [Related]
17. Post-rapamycin proteinuria: incidence, evolution, and therapeutic handling at a single center.
Pinheiro HS; Amaro TA; Braga AM; Bastos MG
Transplant Proc; 2006 Dec; 38(10):3476-8. PubMed ID: 17175309
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of histological features of polyomavirus allograft nephropathy.
Gaber LW; Egidi MF; Stratta RJ; Lo A; Moore LW; Gaber AO
Transplantation; 2006 Jul; 82(2):196-204. PubMed ID: 16858282
[TBL] [Abstract][Full Text] [Related]
19. Expression of the chemokine receptor CXCR3 in human renal allografts--a prospective study.
Hoffmann U; Segerer S; Rümmele P; Krüger B; Pietrzyk M; Hofstädter F; Banas B; Krämer BK
Nephrol Dial Transplant; 2006 May; 21(5):1373-81. PubMed ID: 16421159
[TBL] [Abstract][Full Text] [Related]
20. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
